Biotech Startups

VPCIR develops non-invasive lateral flow diagnostic test sticks that detect living pathogens in saliva, using patented Rolling Circle Amplification technology for point-of-care Tuberculosis testing. Its pipeline extends to other infectious diseases such as Malaria, targeting affordable, accessible diagnostics for global healthcare.

1 investor

Vugene provides automated, reproducible analysis and interpretation of biomedical research data, including statistical modeling, machine learning, and multi-omics data integration. It serves research teams and enterprise clients working with omics and biomedical datasets.

1 investor

vVARDIS develops biomimetic, non-invasive dental products based on P11-4 peptide technology to treat early-stage tooth decay by regenerating enamel without drilling. The Swiss company sells chairside solutions to dental professionals, DSOs, and universities.

1 investor

Vycellix is a biotechnology company developing cell-based immunotherapies, including universal (off-the-shelf) cell platforms and tumor-activated engagers. Its pipeline includes natural killer cell and multi-antigen engager candidates aimed at cancer treatment.

1 investor

Vyriad is a clinical-stage biotechnology company developing oncolytic virus-based therapies for cancer treatment. It works on engineering viral cancer immunotherapies and GMP virus manufacturing, and has pharma partnerships with companies including Novartis, Regeneron, and Merck KGaA.

1 investor

Vysioneer builds AI software that analyzes tumor lesions in medical imaging to assess treatment efficacy, aiming to make oncology clinical trials smaller and faster. It serves cancer researchers and drug developers by extracting all-lesion features and biomarkers that predict treatment outcomes.

1 investor

Vytrus is a biotechnology company focused on plant-based science and product development. The company develops formulations and products leveraging botanical expertise for commercial applications.

1 investor

SANS develops a coffee-free beverage that recreates the taste and aroma of coffee using fermentation-based biotechnology, made from over 12 natural "super" ingredients and containing no caffeine. The wellness drink is marketed to coffee lovers as a healthier, sustainability-minded alternative to conventional coffee.

1 investor

M3 Wake Research operates a network of wholly owned clinical trial sites that recruit participants and conduct investigational studies for biopharmaceutical, biotechnology, medical device, and pharmaceutical companies as well as contract research organizations. It serves sponsors and patients across North America, handling participant recruitment, trial execution, and data analysis.

1 investor

Walder Ventures is a mission-driven investment vehicle established by Joseph and Elizabeth Walder to support programs and organizations benefiting the Chicago region, with a focus on life sciences and sustainability. Its inaugural investment is in Portal Innovations, a Chicago-based incubator for life sciences, medtech, and bioinformatics entrepreneurs.

1 investor

Warhound develops technology to improve the health, safety, and performance of working dogs used by police, firefighters, search-and-rescue teams, and military forces in the United States. It combines licensed technology from Colossal Biosciences and Anduril, with animal welfare central to its mission.

1 investor

Watchmaker Genomics develops and manufactures purpose-designed enzymes, reagents, and workflows for molecular biology and genomics applications, including inherited disease, somatic oncology, transcriptomics, and epigenomics research. It operates as an OEM supplier serving genomics technology developers and high-throughput sequencing labs.

1 investor

Watershed is a biotech company developing sustained-release, self-clearing drug therapies delivered directly into the bladder, initially targeting bladder cancer with plans to expand into other disease states. Its platform uses small molecule and peptide approaches, including combination dosing of active agents.

1 investor

WaveClear is a personalized mindset and skills training tool for League of Legends players that tracks focus and in-game performance in real-time (without hardware) to help gamers improve consistency, ignore toxicity, and rank up. It combines wellness research and pro-coaching methods to train mindset, mechanics, and goal setting during gameplay.

1 investor

Wavefront Dynamics is a medical device company that develops diagnostic and lens design systems for vision care, built on Shack-Hartmann wavefront sensor technology. Its WaveDȳn Vision Analyzer captures thousands of data points across the pupil to help clinicians measure and treat highly aberrated eyes.

1 investor

Wavefront develops quantitative 3D cell imaging technology for biomedical researchers to accelerate discoveries in cell science and healthcare applications.

1 investor

WaveGuide develops a portable time-domain NMR (nuclear magnetic resonance) platform based on technology licensed from Harvard University, targeting applications in medical diagnostics, pharmaceuticals, food safety, oil & gas, and cannabis testing. The company applies magnetic nanoparticle methods toward uses such as tuberculosis and ovarian cancer screening.

1 investor

Paradoxx develops hair care products formulated with natural ingredients and proprietary technology to promote scalp health and hair thickness. The brand targets consumers seeking scientifically-backed, clean beauty solutions for fuller, healthier hair.

1 investor

Palta provides design and communication services for science-driven companies, helping biotech and innovation firms communicate their research and value to stakeholders. The company partners with companies across multiple sectors including biotech, deeptech, and climate-focused innovators globally.

1 investor

WeCare Bio is a probiotic company serving the probiotic industry with research and development applications. The company has a team of 200+ researchers, primarily at master's level (70%+) and doctoral level (10%).

1 investor

Welgene manufactures and supplies cell culture products for life science research, including specialized media (such as mesenchymal stem cell and keratinocyte media), cell viability assay reagents, ultrapure water, and cell culture plate packages. Its products serve laboratory researchers in biotechnology and molecular biology.

1 investor

Nocturol, Inc. (Wellesley Pharma) is developing a treatment for nocturia, a medical condition in which people are woken frequently at night by the need to urinate. The company targets the hundreds of millions of people who experience multiple nighttime bathroom visits.

1 investor

Wellington Partners is a venture capital firm founded in 1998 that invests in early- and growth-stage life science companies with a focus on biotech and medtech. It backs startups from Germany, Europe and beyond.

1 investor

WeNou is a Lisbon-based molecular biology laboratory offering DNA-based analytical services, focused on Next Generation Sequencing (NGS), to identify species in food and feed samples for authenticity, safety and quality testing. It serves food chain stakeholders such as retailers and food companies, and also applies its methods to environmental quality and veterinary animal disease diagnostics.

1 investor